Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss ¥ in Thousands, $ in Thousands |
6 Months Ended | 12 Months Ended | |||||
|---|---|---|---|---|---|---|---|
|
Jun. 30, 2024
CNY (¥)
¥ / shares
shares
|
Jun. 30, 2024
USD ($)
$ / shares
shares
|
Jun. 30, 2023
CNY (¥)
¥ / shares
shares
|
Dec. 31, 2023
CNY (¥)
¥ / shares
shares
|
Dec. 31, 2023
USD ($)
$ / shares
shares
|
Dec. 31, 2022
CNY (¥)
¥ / shares
shares
|
Dec. 31, 2021
CNY (¥)
¥ / shares
shares
|
|
| Net revenues | |||||||
| Total net revenues | ¥ 32,305 | $ 4,446 | ¥ 92,152 | ¥ 162,367 | $ 22,868 | ¥ 183,188 | ¥ 357,552 |
| Cost of revenues | (9,951) | (1,369) | (33,726) | (68,942) | (9,710) | (70,537) | (85,290) |
| Gross profit | 22,354 | 3,077 | 58,426 | 93,425 | 13,158 | 112,651 | 272,262 |
| Operating expenses: | |||||||
| Selling and marketing expenses | (36,529) | (5,027) | (80,742) | (157,004) | (22,114) | (127,696) | (274,670) |
| General and administrative expenses | (24,279) | (3,341) | (23,654) | (44,666) | (6,291) | (64,708) | (72,788) |
| Research and development expenses | (8,700) | (1,197) | (7,671) | (11,267) | (1,587) | (19,799) | (35,651) |
| Impairment of long-lived assets | (300) | (41) | (1,515) | (1,515) | (213) | (19,743) | |
| Total operating expenses | (69,808) | (9,606) | (113,582) | (214,452) | (30,205) | (231,946) | (383,109) |
| Loss from operations | (47,454) | (6,529) | (55,156) | (121,027) | (17,047) | (119,295) | (110,847) |
| Other income/(expenses): | |||||||
| Interest income/(expenses), net | (442) | (61) | 69 | (143) | (20) | (174) | 625 |
| Foreign exchange (loss)/gain | (259) | (259) | (37) | 444 | (149) | ||
| Gain from equity method investments | 427 | 59 | 95 | 181 | 26 | 26 | 258 |
| Impairment of long-term investment | (700) | ||||||
| Impairment of goodwill | (69,853) | ||||||
| Change in fair value of warrant liability | 2,338 | 322 | 11,551 | 20,732 | 2,920 | 11,219 | |
| Other income, net | 4,456 | 613 | 13,002 | 17,545 | 2,471 | 5,692 | 8,868 |
| Loss before income taxes | (40,675) | (5,596) | (30,698) | (82,971) | (11,687) | (171,941) | (101,945) |
| Income tax benefit | 5,451 | ||||||
| Net loss | (40,675) | (5,596) | (30,698) | (82,971) | (11,687) | (166,490) | (101,945) |
| Net loss attributable to TuanChe Limited’s ordinary shareholders | (40,675) | (5,596) | (30,698) | ||||
| Other comprehensive (loss) income: | |||||||
| Foreign currency translation adjustments | (27) | (4) | (34) | 125 | 18 | (1,008) | (1,603) |
| Total other comprehensive (loss) income | (27) | (4) | (34) | 125 | 18 | (1,008) | (1,603) |
| Total comprehensive loss | (40,702) | (5,600) | (30,732) | ¥ (82,846) | $ (11,669) | ¥ (167,498) | ¥ (103,548) |
| Comprehensive loss attributable to: | |||||||
| TuanChe Limited’s shareholders | ¥ (40,702) | $ (5,600) | ¥ (30,732) | ||||
| Net loss attributable to the TuanChe Limited’s ordinary shareholders per share | |||||||
| Net loss attributable to the TuanChe Limited’s ordinary shareholders per share basic (in Dollars per share and Yuan Renminbi per share) | (per share) | ¥ (0.1) | $ (0.01) | ¥ (0.08) | ¥ (0.2) | $ (0.03) | ¥ (0.52) | ¥ (0.33) |
| Net loss attributable to the TuanChe Limited’s ordinary shareholders per share diluted (in Dollars per share and Yuan Renminbi per share) | (per share) | ¥ (0.1) | $ (0.01) | ¥ (0.08) | ¥ (0.2) | $ (0.03) | ¥ (0.52) | ¥ (0.33) |
| Weighted average number of ordinary shares | |||||||
| Weighted average number of ordinary shares basic (in Shares) | 421,273,519 | 421,273,519 | 399,544,700 | 406,802,365 | 406,802,365 | 319,539,180 | 306,792,324 |
| Weighted average number of ordinary shares diluted (in Shares) | 421,273,519 | 421,273,519 | 399,544,700 | 406,802,365 | 406,802,365 | 319,539,180 | 306,792,324 |
| Share-based compensation expenses included in: | |||||||
| Selling and marketing expenses | ¥ 74 | $ 10 | ¥ 1,556 | ¥ 2,123 | |||
| General and administrative expenses | 7,720 | 1,087 | 4,868 | 3,928 | |||
| Research and development expenses | 1,752 | 247 | 3,858 | 3,746 | |||
| Auto shows | |||||||
| Net revenues | |||||||
| Total net revenues | ¥ 19,948 | $ 2,745 | ¥ 69,286 | 111,349 | 15,683 | 53,962 | 242,860 |
| Special promotion events | |||||||
| Net revenues | |||||||
| Total net revenues | 224 | 31 | 589 | 3,166 | 446 | 1,609 | 3,994 |
| Referral service for commercial bank | |||||||
| Net revenues | |||||||
| Total net revenues | 2,572 | 2,572 | 362 | 44,202 | 67,010 | ||
| Online marketing | |||||||
| Net revenues | |||||||
| Total net revenues | 2,569 | 354 | 8,753 | 23,411 | 3,297 | 50,757 | 14,489 |
| Others | |||||||
| Net revenues | |||||||
| Total net revenues | ¥ 9,564 | $ 1,316 | ¥ 10,952 | ¥ 21,869 | $ 3,080 | ¥ 32,658 | ¥ 29,199 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of noncash expense for share-based payment arrangement including general and administrative expenses. No definition available.
|
| X | ||||||||||
- Definition Amount of noncash expense for share-based payment arrangement including Research and development expenses. No definition available.
|
| X | ||||||||||
- Definition Amount of noncash expense for share-based payment arrangement including selling and marketing expenses. No definition available.
|
| X | ||||||||||
- Definition Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate cost of goods produced and sold and services rendered during the reporting period. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of other-than-temporary decline in value that has been recognized against investment accounted for under equity method of accounting. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of expense (income) related to adjustment to fair value of warrant liability. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of impairment loss from asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of income (loss) for proportionate share of equity method investee's income (loss). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of interest income (expense) classified as nonoperating. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount after tax and reclassification adjustments of other comprehensive income (loss). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The aggregate total amount of expenses directly related to the marketing or selling of products or services. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|